Tag Archives: Biotechnology Industry

Diversity Critical to Building Rich Bioscience Centers

Warren Ribley

Whether producing natural gas from coal or creating lifesaving medicines, unique experiences are what often lead to great discoveries. The more diverse the backgrounds and interests of those working in life sciences, the richer our discoveries are bound to be. Considering the diversity of our country, it’s not surprising that the U.S. is the most prolific country in the world in terms of life science or bioscience discoveries. And many of these are happening right Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Business Solutions at the 2013 BIO International Convention

Piggy Bank

Do you wish to save money for your company? Is your company a member of BIO or state and regional biotech associations? Would you like to be recognized as a preferred supplier? If you answered yes to any of these questions, then perhaps you should consider BIO Business Solutions® – the largest cost-savings program for the biotech industry. Nearly 3,000 companies utilize this group savings program to obtain discounts from industry leading suppliers and service Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Debunking Ag Biotech’s Top 5 Myths

Book

On Reason.com, award-winning science correspondent Ronald Bailey takes on the Institute for Responsible Technology (IRT), an organization opposed to crop biotechnology. IRT published a list of reasons to avoid GMOs. Bailey says, “it’s a mish-mash of misinformation and disinformation. All of the institute’s assertions are unfounded.” In a detailed article chock full of scientific cites, Bailey debunks the following IRT Myths: 1. “GMOs Are Unhealthy” 2. “GMOs Increase Herbicide Use” 3. “Genetic Engineering Creates Dangerous Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Despite Low Funding, Biotech Productivity Remains High In 2013

John Milligan

At the 2013 BIO CEO & Investor Conference, John Milligan, President and COO of Gilead Sciences, spoke in a standing room only fireside chat with Joel Sendek, Managing Director of Stifel Nicolaus, who moderated the discussion. Nicolaus noted that Gilead’s market cap has grown at an astounding 40 fold over the past 15 years, and asked Milligan to speak about the current state of the biotech industry. Milligan explained that biotech is not becoming more Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Word on the Street – Biotech Stocks Only Have Room to Go Up

The Opening Lunch Plenary at this year’s BIO CEO & Investor Conference was a lively discussion between portfolio managers and senior buy-side analysts looking to forecast the year ahead in biotech. BIO’s own, Celia Economides, Director, Investor Relations & Programs, reminded us all where we were 15 years ago at the inception of this event. At the 1999 event, there were 18 presenting companies, zero 1X1 meetings scheduled and 271 attendees.  As of day one, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,